BIOMAT Database Logo BIOMAT Database Logo

Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase. 2007

Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Division of Immunology/Allergy, The Hospital for Sick Children and The University of Toronto, Toronto, Ontario, Canada.

We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.

UI MeSH Term Description Entries
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
December 2005, Pediatrics,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
[Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol].
April 1992, Archives francaises de pediatrie,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
August 1993, The Journal of clinical investigation,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Severe combined immunodeficiency disease with adenosine deaminase deficiency.
October 1979, The Tohoku journal of experimental medicine,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
[Adenosine deaminase deficiency and severe combined immunodeficiency].
February 1980, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Severe combined immunodeficiency and adenosine deaminase deficiency.
April 1975, The New England journal of medicine,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
March 1987, The New England journal of medicine,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Adenosine deaminase deficiency in a child with severe combined immunodeficiency.
January 1973, Clinical genetics,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
Metabolic findings in a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
January 1984, Advances in experimental medicine and biology,
Maitham Husain, and Eyal Grunebaum, and Ahmed Naqvi, and Adelle Atkinson, and Bo-Yee Ngan, and Alessandro Aiuti, and Chaim M Roifman
A family of adenosine deaminase deficiency with severe combined immunodeficiency.
June 1979, Jinrui idengaku zasshi. The Japanese journal of human genetics,
Copied contents to your clipboard!